CUSIP: 03476J107
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,911,617
-
Share change
-
-203,006
-
Total reported value
-
$3,984,349
-
Price per share
-
$0.81
-
Number of holders
-
30
-
Value change
-
-$174,223
-
Number of buys
-
6
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 03476J107?
CUSIP 03476J107 identifies ANGN - ANGION BIOMEDICA CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 03476J107:
Institutional Holders of ANGION BIOMEDICA CORP - COM (ANGN) as of Q4 2022
As of 31 Dec 2022,
ANGION BIOMEDICA CORP - COM (ANGN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,911,617 shares.
The largest 10 holders included
BVF INC/IL, Nantahala Capital Management, LLC, CM Management, LLC, VANGUARD GROUP INC, Park West Asset Management LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and RAYMOND JAMES & ASSOCIATES.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.